Target intelligence / Profile preview

No classical pharmacological target

Molecular classification
Other
01

Overview

The term "No classical pharmacological target" refers to a classification for therapeutic agents that do not exert their effects by binding to specific biological macromolecules such as receptors, enzymes, or ion channels. Instead, these substances typically function through direct physicochemical interactions within the body, such as chemical neutralization, osmotic pressure alteration, or physical adsorption (StatPearls, 2023). Common examples include antacids like aluminum hydroxide, which neutralize gastric acid through a simple acid-base reaction, and osmotic laxatives like magnesium sulfate that draw water into the intestinal lumen (NCBI, 2022). Chelating agents also fall into this category as they work by chemically sequestering metal ions rather than interacting with a protein binding site (Britannica, 2024). Because these agents lack a specific molecular target, they do not adhere to traditional pharmacological principles like the lock-and-key model or structure-activity relationships. This classification is vital for drug databases and regulatory bodies to distinguish between targeted molecular therapies and those with broad, non-specific mechanisms of action (ChEMBL, 2024). While effective, these agents can present unique safety challenges, such as systemic electrolyte imbalances or interference with the absorption of other medications.

Other names
Non-protein targetNon-specific targetPhysicochemical mechanismNon-classical target
02

Mechanism of action

Physicochemical interaction including chemical neutralization, osmotic gradient creation, physical adsorption, and surface tension modification.

03

Biological functions

Other
04

Disease associations

Gastrointestinal disorderPoisoningConstipationCerebral edemaOther
05

Safety considerations

Electrolyte imbalanceMetabolic alkalosisReduced bioavailability of co-administered drugs via adsorptionSystemic accumulation of non-absorbed components (e.g., aluminum)
06

Interacting drugs

Aluminum hydroxide

6 more in the full profile.

Beyond the preview

Go deeper on No classical pharmacological target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on No classical pharmacological target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call